Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/14/14 → 05/15/16 |
Funding
- Merck Sharp and Dohme Limited Liability Corporation: $8,241.43
A PH 2/3 clinical trial to study the efficacy and safety of the combination regimen of MK5172 and MK-8742 in subjects with Chronic Hepatitis C virus infection with advanced cirrhosis and Child-Pugh (CP)-B hepatic insufficiency
- Talal, Andrew (PI)
- Martinez, Anthony (CoI)
Project: Research